Business
Omnyx, LLC, the digital pathology joint venture between University of Pittsburgh Medical Center (UPMC) and GE Healthcare, today announced a memorandum of understanding with Argent Global Services, a process engineering and management consulting...
Originally published March 11, 2015 By Simon Häger, Product Manager, Sectra Digital Pathology Solution Multi-Disciplinary Team Meetings (MDT) are a cornerstone of cancer care. Several recent studies [1-3] clearly demonstrate that MDTs, or...
After thorough testing, and internal clinical validation, Herlev University Hospital selects Visiopharm’s ONCOtopix™ Dx – a platform for computer assisted quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization...
Visiopharm continues to make news this year with appointment of Patrik Dahlén to its Board of Directors as Chairman. Today Visiopharm announces that Patrik Dahlén, previously the CEO of Dako, has joined the Visiopharm Board of Directors as...
SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced that...
Last week Simon Häger, Product Manager from Sectra, wrote an interesting article on their website entitled "How to Build a Business Case to Justify the Investment in Digital Pathology". Simon breaks down the gains into some basic categories...
